EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients

Marilena La Sorda, Desy De Lorenzis, Alessandra Battaglia, Barbara Fiori, Rosalia Graffeo, Rosaria Santangelo, Tiziana D'Inzeo, Gennaro De Pascale, Giovanni Schinzari, Romina Rose Pedone, Ernesto Rossi, Maurizio Sanguinetti iD und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marilena La Sorda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Sciences and Infectious Diseases, A. Gemelli University Hospital Foundation IRCCS, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Flow Cytometry, Neutrophils, Monocytes, Bacterial Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU funding for the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We developed a flow cytometry (FC) assay enabling the rapid and accurate identification of bacterial and viral infections using whole blood samples. The streamlined flow cytometry assay is designed to be user-friendly, making it accessible even for operators with limited experience in FC techniques. The key components of the assay focus on the expression levels of specific surface markers—CD64 on polymorphonuclear neutrophils (PMN) as a marker for bacterial infection, and CD169 on monocytes (MO) for viral infection. The strong performance indicated by an area under the receiver operating characteristic (ROC) curve of 0.94 for both PMN CD64 positive predictive value (PPV) 97.96% and negative predictive value (NPV) 76.67%, and MO CD169 PPV 82.6% and NPV 86.9%, highlight the assay’s robustness in differentiating between bacterial and viral infections accurately. The FC assay includes the assessment of immune system status through HLA-DR and IL-1R2 modulation in MO, providing a useful insight into the patients’ immune response. The significant increase in the frequency of MO exhibiting reduced HLA-DR expression and elevated IL-1R2 levels in infected patients (compared to healthy controls) underscores the potential of these markers as indicators of infection severity. Although the overall correlation between HLA-DR and IL-1R2 expression levels was not significant across all patients, there was a trend in patients with more severe disease suggesting that these markers may have the potential to assist in stratifying patient risk. The present FC assay has the potential to become routine in the clinical microbiology laboratory community and to be helpful in guiding clinical decision making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryNeutrophilsMonocytesBacterial InfectionsBiomarkersVirus DiseasesReceptors, IgGHumansFemaleMaleAdultMiddle AgedFeverAgedSialic Acid Binding Ig-like Lectin 1ROC CurveHLA-DR Antigens

Stichwörter der Autor:innen

CD169CD64HLA-DRbacterial and viral infectionflow cytometryimmune dysfunctioninterleukin-1 receptor 2monocytespolymorphonuclear neutrophils

Substanzen

BiomarkersReceptors, IgGSialic Acid Binding Ig-like Lectin 1HLA-DR Antigens

Autor:innen und Institutionen

  • Department of Laboratory Sciences and Infectious Diseases, A. Gemelli University Hospital Foundation IRCCS, 00168 Rome, Italy.
  • Department of Life Science and Public Health, Catholic University of the Sacred Heart, 00168 Rome, Italy.
  • Emergency Department, A. Gemelli University Hospital Foundation IRCCS, 00168 Rome, Italy.
  • Medical Oncology, A. Gemelli University Hospital Foundation IRCCS, 00168 Rome, Italy.
  • Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Catholic University of the Sacred Heart, 00168 Rome, Italy.
  • Laboratory of Oncology and Flow Cytometry, A. Gemelli University Hospital Foundation IRCCS, 00168 Rome, Italy.

ORCID-Profile: Maurizio Sanguinetti, Michela Sali

Förderung

  • EU funding for the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases

Zitieren

APA

La Sorda, M., De Lorenzis, D., Battaglia, A., Fiori, B., Graffeo, R., Santangelo, R., D'Inzeo, T., De Pascale, G., Schinzari, G., Pedone, R. R., Rossi, E., Sanguinetti, M., Sali, M., & Fattorossi, A. (2024). A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111632

Vancouver

La Sorda M, De Lorenzis D, Battaglia A, Fiori B, Graffeo R, Santangelo R, et al. A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111632

BibTeX
@article{LaSorda2024,
  author = {La Sorda, Marilena and De Lorenzis, Desy and Battaglia, Alessandra and Fiori, Barbara and Graffeo, Rosalia and Santangelo, Rosaria and D'Inzeo, Tiziana and De Pascale, Gennaro and Schinzari, Giovanni and Pedone, Romina Rose and Rossi, Ernesto and Sanguinetti, Maurizio and Sali, Michela and Fattorossi, Andrea},
  title = {A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111632}
}
Kostenlos starten →